Lucid Diagnostics (LUCD) Depreciation & Amortization (CF) (2021 - 2026)
Lucid Diagnostics (LUCD) reported Depreciation & Amortization (CF) of $222000.0 for Q1 2026, little changed on a YoY basis from $221000.0 in Q1 2025, and up 6.22% quarter-over-quarter from $209000.0 in Q4 2025.
Lucid Diagnostics (LUCD) Depreciation & Amortization (CF) (2021 - 2026) Analysis & Trends
Lucid Diagnostics has reported Depreciation & Amortization (CF) for 6 years, with the latest figure at $222000.0 in Q1 2026.
- For the quarter ending Q1 2026, Depreciation & Amortization (CF) changed 0.45% year-over-year to $222000.0; the trailing twelve-month figure through Mar 2026 stood at $873000.0 (down 1.58% YoY), and the FY2025 full-year result was $872000.0, down 25.28% from the prior year.
- Depreciation & Amortization (CF) for Q1 2026 stood at $222000.0, up from $209000.0 in the prior quarter.
- The five-year high for Depreciation & Amortization (CF) was $704000.0 in Q2 2022, with the low at $24000.0 in Q1 2022.
- Historically, Depreciation & Amortization (CF) has averaged $393882.4 across 5 years, with a median of $229000.0 in 2024.
- Annual changes were most pronounced in 2022 — Depreciation & Amortization (CF) soared 61400.0% — and 2024, when it sank 65.6%.
- Lucid Diagnostics' Depreciation & Amortization (CF) stood at $615000.0 in 2022, then increased by 2.28% to $629000.0 in 2023, then plunged by 64.71% to $222000.0 in 2024, then fell by 5.86% to $209000.0 in 2025, then increased by 6.22% to $222000.0 in 2026.
- The last three Depreciation & Amortization (CF) figures came in at $222000.0 (Q1 2026), $209000.0 (Q4 2025), and $220000.0 (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation & Amortization (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | 381.00 Mn |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | 120.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 749.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | 351.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | 40.90 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 67.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | 78.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 123.40 Mn |
| 10 | Lucid Diagnostics | 149.20 Mn | 121.33 Mn | -325,000.00 | 222,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 222,000.00 |
| Mar 31, 2026 | 222,000.00 |
| Dec 31, 2025 | 209,000.00 |
| Dec 31, 2025 | 209,000.00 |
| Sep 30, 2025 | 220,000.00 |
| Sep 30, 2025 | 220,000.00 |
| Jun 30, 2025 | 222,000.00 |
| Jun 30, 2025 | 222,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Mar 31, 2025 | 221,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Dec 31, 2024 | 222,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Sep 30, 2024 | 215,000.00 |
| Jun 30, 2024 | 229,000.00 |
| Jun 30, 2024 | 229,000.00 |
| Mar 31, 2024 | 501,000.00 |
| Mar 31, 2024 | 501,000.00 |
| Dec 31, 2023 | 629,000.00 |
| Dec 31, 2023 | 629,000.00 |